Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
1991-7-26
|
pubmed:abstractText |
Fifty-three patients, 28 females and 25 males, aged from 21 to 68 years, affected with mono- and bilateral intermittent hydrarthrosis of the knee and of a non-inflammatory nature, were included in an open study. All of the knees involved were treated with intra-articular infiltrations with Rifamycin SV. The weekly dosage of Rifamycin SV was 500 mg; the average duration of treatment was 6 weeks. Follow-up 1 year after the end of treatment showed a decrease or regression in joint effusion in all of the knees treated.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
0009-4749
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
75
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
343-6
|
pubmed:dateRevised |
2010-6-18
|
pubmed:meshHeading |
pubmed-meshheading:2098221-Adult,
pubmed-meshheading:2098221-Aged,
pubmed-meshheading:2098221-Female,
pubmed-meshheading:2098221-Follow-Up Studies,
pubmed-meshheading:2098221-Humans,
pubmed-meshheading:2098221-Hydrarthrosis,
pubmed-meshheading:2098221-Injections, Intra-Articular,
pubmed-meshheading:2098221-Knee Joint,
pubmed-meshheading:2098221-Male,
pubmed-meshheading:2098221-Middle Aged,
pubmed-meshheading:2098221-Rifamycins
|
pubmed:articleTitle |
The treatment of idiopathic and secondary hydrarthrosis of the knee by intra-articular Rifamycin SV.
|
pubmed:publicationType |
Journal Article
|